Please use this identifier to cite or link to this item:
|Title:||Ion Channels in Genetic Epilepsy: From Genes and Mechanisms to Disease-Targeted Therapies.|
|Authors:||Oyrer, Julia;Maljevic, Snezana;Scheffer, Ingrid E;Berkovic, Samuel F;Petrou, Steven;Reid, Christopher A|
|Affiliation:||The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Melbourne, Australia|
Department of Medicine, Austin Health, University of Melbourne, Heidelberg, Victoria, Australia
Department of Paediatrics, University of Melbourne, Royal Children's Hospital, Melbourne, Australia
|Citation:||Pharmacological reviews 2018; 70(1): 142-173|
|Abstract:||Epilepsy is a common and serious neurologic disease with a strong genetic component. Genetic studies have identified an increasing collection of disease-causing genes. The impact of these genetic discoveries is wide reaching-from precise diagnosis and classification of syndromes to the discovery and validation of new drug targets and the development of disease-targeted therapeutic strategies. About 25% of genes identified in epilepsy encode ion channels. Much of our understanding of disease mechanisms comes from work focused on this class of protein. In this study, we review the genetic, molecular, and physiologic evidence supporting the pathogenic role of a number of different voltage- and ligand-activated ion channels in genetic epilepsy. We also review proposed disease mechanisms for each ion channel and highlight targeted therapeutic strategies.|
|Appears in Collections:||Journal articles|
Files in This Item:
There are no files associated with this item.
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.